Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Cancers|January 24, 2019
PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAPSouheyla Bensalma, Soumaya Turpault, Annie-Claire Balandre, et al.Journal of Neuroscience Research|May 12, 2007
Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cellsJulie Deguil, David Jailloux, Guylène Page, et al.American Journal of Human Genetics|June 15, 2006
Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failureArnaud Lacombe, Hane Lee, Laila Zahed, et al.Cellular Signalling|August 6, 2014
Signaling pathways in breast cancer: therapeutic targeting of the microenvironmentArmel Herve Nwabo Kamdje, Paul Faustin Seke Etet, Lorella Vecchio, et al.Annals of the New York Academy of Sciences|August 5, 2006
Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in ratColin Debaigt, Annie-Claire Meunier, Stephanie Goursaud, et al.Annals of the New York Academy of Sciences|August 5, 2006
Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicityClaire-Marie Rangon, Eleni Dicou, Stéphanie Goursaud, et al.Journal of Molecular Neuroscience : MN|October 5, 2014
Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumorsSouheyla Bensalma, Corinne Chadeneau, Thibaut Legigan, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null miceArnaud Lacombe, Vincent Lelievre, Charles E Roselli, et al.Molecular Pharmaceutics|October 15, 2015
A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 PathwaySonia Aroui, Lucie Dardevet, Wafa Ben Ajmia, et al.World Journal of Clinical Cases|December 18, 2014
New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersArmel Hervé Nwabo Kamdje, Paul Faustin Seke Etet, Lorella Vecchio, et al.Pageof 4